Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG34499

KTN1 Knockout A549 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Lung adenocarcinoma

The KTN1 Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population from A-549 lung adenocarcinoma cells, designed to study the ER-anchored kinesin-1 receptor kinectin (KTN1). KTN1 mediates microtubule-dependent ER positioning and interacts with KIF5B and RhoA. This model enables investigation of ER morphology, vesicle trafficking, and organelle distribution in a cancer-relevant context. Applications include immunofluorescence for ER markers, live-cell imaging, and co-immunoprecipitation, aiding research into lung cancer biology and ER stress.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    A549

    Sex of Donor

    Male

    Age

    58 years

    Derived From Site

    Lung

    Gene Name

    KTN1

    Gene Identifier

    NCBI Gene ID 3895

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KTN1 Knockout A-549 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal knockout cell population derived from the A-549 human lung adenocarcinoma cell line. This product is designed for loss-of-function studies of the KTN1 gene, which encodes kinectin, a kinesin-1 receptor critical for endoplasmic reticulum (ER) positioning and intracellular trafficking. The polyclonal format provides a heterogeneous pool of gene-disrupted cells, offering a robust model to investigate KTN1-dependent cellular processes without relying on clonal variation.

The host cell line A-549 was originally isolated from the alveolar basal epithelium of a 58-year-old Caucasian male diagnosed with lung carcinoma. As a well-characterized model of human lung adenocarcinoma, A-549 cells are extensively employed in cancer research to study tumor biology, drug sensitivity, and metastatic behavior. Their epithelial morphology and high transfection efficiency make them particularly suitable for CRISPR-mediated gene editing, enabling functional genomics studies in a disease-relevant context.

KTN1 serves as a membrane anchor for kinesin-1 (KIF5B) on the ER, facilitating microtubule-dependent extension and distribution of the ER network throughout the cytoplasm. This interaction is regulated by upstream factors including Rho GTPases and potential phosphorylation events, whereas downstream outcomes involve ER network organization, vesicle trafficking, and secretion. KTN1 also associates with ribosomes and the small GTPase RhoA, positioning it at the intersection of cytoskeletal dynamics and organelle positioning pathways.

In the context of A-549 cells, disruption of KTN1 function leads to aberrant ER morphology and impaired intracellular trafficking, phenotypes that are highly relevant to lung cancer cell biology. Given the reliance of cancer cells on efficient secretion and ER homeostasis for proliferation and migration, this knockout model offers a powerful tool to study how KTN1 loss influences oncogenic processes, including cell motility and the response to ER stress.

This product is ideally suited for a range of experimental applications, such as investigating ER stress and the unfolded protein response, analyzing organelle positioning dynamics, and exploring the molecular basis of lung adenocarcinoma. Representative assays include immunofluorescence staining of ER markers like calreticulin, live-cell imaging of ER dynamics, co-immunoprecipitation with KIF5B, microtubule co-sedimentation assays, and cell migration assays. For further information or to discuss how this knockout cell model can accelerate your research, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)